Successful Outcome of Programmed Death 1 Blockade Plus GemOx for Epstein-Barr Virus-Associated Primary Nodal T/NK Cell Lymphoma: A Case Report.

Xia, Liang; Zhang, Han-Shuo; Bao, Jing; Zhao, Yu-Chen; Xia, Hai-Long

Xia, Liang; Zhang, Han-Shuo; Bao, Jing; Zhao, Yu-Chen; Xia, Hai-Long.

Afiliación

Xia L; Department of Hematology, The First Affiliated Hospital, Anhui Medical University, Hefei, China.
Zhang HS; Department of Hematology, The First Affiliated Hospital, Anhui Medical University, Hefei, China.
Bao J; Department of Hematology, The First Affiliated Hospital, Anhui Medical University, Hefei, China.
Zhao YC; Department of Hematology, The First Affiliated Hospital, Anhui Medical University, Hefei, China.
Xia HL; Department of Hematology, The First Affiliated Hospital, Anhui Medical University, Hefei, China.

Front Oncol ; 11: 706865, 2021.

Article en En | MEDLINE | ID: mdl-34277451

Palabras clave

EBV-associated nodal TNKL; Gemcitabine and oxaliplatin; PD-1 blockade; case report; tislelizumab

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google